2012 .03 ~ 2015 .08서울대학교 의학 박사 2010 .03 ~ 2012 .02서울대학교 의학 석사 2000 .03 ~ 2006 .02서울대학교 의학 학사
경력
2017 .03 ~ 현재서울아산병원 유방외과 조교수 2016 .03 ~ 2017 .02서울아산병원 유방외과 촉탁임상조교수 2015 .03 ~ 2016 .02서울아산병원 유방외과 임상전임강사 2012 .07Visiting doctor Dana Farber Cancer Institute and Brigham Women’s Hospital Harvard Medical School 2012 .03 ~ 2014 .02서울대학교병원 유방내분비외과 진료교수 2011 .03 ~ 2012 .02서울대학교병원 유방내분비외과 전임의 2007 .03 ~ 2011 .02서울대학교병원 외과 전공의 2006 .03 ~ 2007 .02서울대학교병원 인턴
논문
A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery.
Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment.
International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries.
Impact of Chemotherapy-Induced Ovarian Dysfunction on Response to Neoadjuvant Chemotherapy in Breast Cancer.
Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples.
The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women.
The reality in the follow-up of breast cancer survivors: survey of Korean Breast Cancer Society.
The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.
Low rates of additional cancer detection by MRI in newly diagnosed breast cancer patients who receive preoperative mammography and ultrasonography
Low rates of additional cancer detection by magnetic resonance imaging in newly diagnosed breast cancer patients who undergo preoperative mammography and ultrasonography.
Nomogram for predicting breast conservation after neoadjuvant chemotherapy.
Phase II randomized study of neoadjuvant METformin plus letrozole vs placebo plus letrozole for estrogen receptor positive pOstmenopausal bReast cancer (METEOR)
Grade of ductal carcinoma in situ accompanying infiltrating ductal acarcinoma as an independent prognostic factor
Preoperative serum tissue polypeptide-specific antigen is a valuable prognostic marker in breast cancer
Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer
Reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients
Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision
Limited value and utility of breast MRI in patients undergoing breast conserving surgery
Sclerosing adenosis diagnosed by needle biopsy: potential safety of follow up by observational study
Validation of a scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia using an ultrasound-guided core needle biopsy
Clinicopathological Characteristics and Factors Affecting Recurrence of Ductal Carcinoma In Situ in Korean Women
The patient underwent axillary lymph node dissection was treated with a mixture of Poloxamer and Alginate (Guardix-SG®) Impact on range of action: Single-institution, prospective, randomized, double-blind investigator pilot study
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor-positive, Human Epidermal Growth Factor-2 (HER2)-negative Breast Cancer
No negative effect of short-term delays in surgery on tumor progression and survival outcomes in invasive breast cancer.
Neutrophil lymphocyte ratio(NLR) change after systemic treatment can be a predictive factor of cancer specific survival(CSS) in stage lV breast cancer.
Multiple Primary Cancers in Breast Cancer Patients
Heterogeneity of Reproductive Risk Factors for Breast Cancer According to Age and Tumor Subtype